177 related articles for article (PubMed ID: 23433122)
1. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
McLenachan S; Chen X; McMenamin PG; Rakoczy EP
Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
[TBL] [Abstract][Full Text] [Related]
2. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
3. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
[TBL] [Abstract][Full Text] [Related]
4. Detection of microvascular retinal changes in type I diabetic mice with optical coherence tomography angiography.
Uehara H; Lesuma T; Stocking P; Jensen N; Kumar SR; Zhang MA; Choi S; Zhang X; Archer B; Carroll L; Ambati BK
Exp Eye Res; 2019 Jan; 178():91-98. PubMed ID: 30268699
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
6. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice.
Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG
Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravitreal injection of human CD34
Yazdanyar A; Zhang P; Dolf C; Smit-McBride Z; Cary W; Nolta JA; Zawadzki RJ; Marsh-Armstrong N; Park SS
Exp Eye Res; 2020 Jan; 190():107865. PubMed ID: 31682846
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
10. Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy.
Wang J; Cui X; Roon P; Smith SB
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2770-81. PubMed ID: 27206247
[TBL] [Abstract][Full Text] [Related]
11. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.
Smith SB; Duplantier J; Dun Y; Mysona B; Roon P; Martin PM; Ganapathy V
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4154-61. PubMed ID: 18469181
[TBL] [Abstract][Full Text] [Related]
12. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
[TBL] [Abstract][Full Text] [Related]
13. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
[TBL] [Abstract][Full Text] [Related]
14. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.
Muir ER; Rentería RC; Duong TQ
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034
[TBL] [Abstract][Full Text] [Related]
15. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
[TBL] [Abstract][Full Text] [Related]
16. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
17. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.
Han Z; Guo J; Conley SM; Naash MI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):574-84. PubMed ID: 23221078
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA
Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227
[TBL] [Abstract][Full Text] [Related]
19. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
